Journal of Hepatology
Volume 33, Issue 3 , Pages 371-375 , September 2000

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine

  • Paul D Richardson

      Affiliations

    • Department of Gastroenterology, Queen's Medical Centre, University Hospital, Nottingham, UK
    • ,
  • Peter D James

      Affiliations

    • Department of Histopathology, Queen's Medical Centre, University Hospital, Nottingham, UK
    • ,
  • Stephen D Ryder

      Affiliations

    • Department of Gastroenterology, Queen's Medical Centre, University Hospital, Nottingham, UK
    • Corresponding Author InformationStephen D. Ryder, Consultant Hepatologist, Queen's Medical Centre, University Hospital, Nottingham, NG7 2UH, UK. Tel: 44 115 970 9155. Fax: 44 115 942 4554.

Received 7 July 1999 ,Revised 19 January 2000 ,Accepted 28 January 2000.

References 

  1. Mistilis SP, Skyring AP, Blackburn CRB. Natural history of active chronic hepatitis, clinical features, course, diagnostic criteria mortality and survival. Aust Ann Med. 1968;17:214–223
  2. Mayer zum Büschenfelde KH, Lohse AW, Manns M, Poralla T. Autoimmunity and liver disease. Hepatology. 1990;12:354–363
  3. Hodges JR, Millward-Sadler GH, Wright R. Chronic active hepatitis: the spectrum of disease. Lancet. 1982;i:550–552
  4. Galbraith RM, Smith M, Mackenzie RM, Tee DE, Doniach D, Williams R. High prevelence of seroimmunological markers in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. N Engl J Med. 1974;290:63–69
  5. Krawitt EL, Kilby AE, Albertini RJ. Immunogenetic studies of autoimmune hepatitis, HLA, immunoglobulin allotypes, and autoantibodies. Hepatology. 1987;7:1305–1310
  6. Johnson PJ, McFarlane BM, Williams R. Autoimmune features in patients with chronic active hepatitis who are seronegative for conventional autoantibodies. J Gastroenterol Hepatol. 1990;5:244–251
  7. Copenhagen Study Group for Liver Disease . Effects of prednisolone on the survival of patients with cirrhosis of the liver. Lancet. 1969;i:119–121
  8. Cook GL, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med. 1971;40:159–175
  9. Soloway RD, Summerskill WHJ, Baggenstoss A. Clinical biochemical and histological remission in severe chronic active liver disease: a controlled study of treatment and early prognosis. Gastroenterology. 1972;63:820–833
  10. Murray Lyon IM, Stern RB, Williams R. Controlled trial of prednisolone and azathioprine in active chronic hepatitis. Lancet. 1973;ii:735–737
  11. Stellon AJ, Keating JJ, Johnson PJ, McFarlane IG, Williams R. Maintenance of remission in patients with autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal. Hepatology. 1988;8:781–784
  12. Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med. 1995;333:958–993
  13. Hegarty JE, Nouri Aria KT, Portmann B, Eddleston ALWF, Williams R. Relapse following azathioprine withdrawal in patients with autoimmune chronic active hepatitis. Hepatology. 1983;3:685–689
  14. Danielsson A, Prytz H. Oral budesonide for treatment of autoimmune chronic active hepatitis. Aliment Pharmacol Ther. 1994;8:585–590
  15. Pratt DS, Flavin DP, Kaplan MM. The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine. Gastroenterology. 1996;110:271–274
  16. Sherman KE, Narkewicz M, Pinto PC. Cyclosporin in the management of corticosteroid resistant type 1 autoimmune chronic active hepatitis. J Hepatol. 1994;21:1040–1047
  17. Van Thiel DH, Wright H, Carroll P, Abu-Elmagd K, Mayer K, Schmidt P, et al.  Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. Am J Gastroenterology. 1995;90:771–776
  18. Kanzler C, Gerken C, Dienes HP. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis - report of three cases. Z Gastroenterol. 1997;35:571–578
  19. Schuppan D, Herold C, Strobel D, Schneider HT, Hahn EG. Successful treatment of therapy-refractory autoimmune hepatitis with mycophenolate mofetil. Hepatology. 1998;28:A1960
  20. Florey HW, Gilliver K, Jennings MA, Sanders AG. Mycophenoloic acid: an antibiotic from Penicillium brevicompactum Dierckx. Lancet. 1946;1:46–49
  21. Sievers TM, Rossi SJ, Ghobrial RM, Arriola E, Nishimura P, Kawano M, et al.  Mycophenolate mofetil. Pharmacotherapy. 1997;17:1178–1197
  22. Epinette WW, Parker CM, Jones EL, Griest MC. Mycophenoloic acid for psoriasis. J Am Acad Dermatol. 1987;17:962–971
  23. Glicklich D, Acharya A. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide. Am J Kidney Dis. 1998;32:318–322
  24. Goldblum R. Therapy of rheumatoid arthritis with mycophenolate mofetil. Clin Exp Rheumatol. 1993;11:S117–S119
  25. Grinyo J, Groth C, Pichlmayr R, Sadek SA. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet. 1995;345:1321–1325
  26. Ross DJ, Waters PF, Levine M, Kramer M, Ruzevich S, Kass RM. Mycophenolate mofetil vs azathioprine immunosuppressive regimens after lung transplantation. J Heart Lung Transplant. 1998;17:768–774
  27. Mathew TH. A blinded, long-term randomised multicentre study of mycophenolate mofetil in cadaveric renal transplantation: results at 3 years. Transplantation. 1998;65:1450–1454
  28. Kobashigawa J, Miller L, Renlund D. A randomised active-controlled trial of mycophenolate mofetil in heart transplant recipients. Transplantation. 1998;66:507–515
  29. Moresof , Seron D, Morales JM, Cruzado JM. Incidence of leukopenia and CMV disease in kidney transplants treated with mycophenolate mofetil combined with low dose cyclosporin and steroid dose. Clin Transplant. 1998;12:198–205
  30. Paterson DL, Singh N, Panebianco A, Wannstedt CF, Wagener MM, Gayowski T, et al.  Infectious complications occuring in liver transplant recipients receiving mycophenolate mofetil. Transplantation. 1998;66:593–598
  31. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993;18:998–1005

PII: S0168-8278(00)80271-8

Journal of Hepatology
Volume 33, Issue 3 , Pages 371-375 , September 2000

Article Tools

* Image Usage & Resolution